Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

Secondary outcome measures include the device’s technical success and quality of life (QoL) changes between six months and ...